Search alternatives:
large decrease » larger decrease (Expand Search), marked decrease (Expand Search), large increases (Expand Search)
ann decrease » nn decrease (Expand Search), a decrease (Expand Search), gain decreased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
via large » a large (Expand Search)
_ ann » _ any (Expand Search), _ anc (Expand Search)
Showing 1 - 20 results of 15,188 for search '(((( via large decrease ) OR ( _ ((we decrease) OR (mean decrease)) ))) OR ( _ ann decrease ))', query time: 0.49s Refine Results
  1. 1
    Overview of the six original ACTIV-3/TICO trials.

    Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2
    ANN architecture.

    ANN architecture. by Abdelfattah Dani (22226715)

    Published 2025
    Save to List
    Saved in:
  3. 3
    ANN architecture and configuration.

    ANN architecture and configuration. by Abdelfattah Dani (22226715)

    Published 2025
    Save to List
    Saved in:
  4. 4
    Table 3_Road transportation is associated with decreased intestinal motility in horses.docx

    Table 3_Road transportation is associated with decreased intestinal motility in horses.docx by Sharanne L. Raidal (3097719)

    Published 2025
    “…Horses with high heart rates, high sweat scores or abnormal demeanour on arrival demonstrated decreased intestinal motility. Salivary cortisol concentrations increased after transportation (mean difference, 95% CI, for T0 vs T1 was 1.66, 1.09−2.53 nmol/L) and were inversely associated with intestinal motility. …”
    Save to List
    Saved in:
  5. 5
    Table 2_Road transportation is associated with decreased intestinal motility in horses.docx

    Table 2_Road transportation is associated with decreased intestinal motility in horses.docx by Sharanne L. Raidal (3097719)

    Published 2025
    “…Horses with high heart rates, high sweat scores or abnormal demeanour on arrival demonstrated decreased intestinal motility. Salivary cortisol concentrations increased after transportation (mean difference, 95% CI, for T0 vs T1 was 1.66, 1.09−2.53 nmol/L) and were inversely associated with intestinal motility. …”
    Save to List
    Saved in:
  6. 6
    Table 5_Road transportation is associated with decreased intestinal motility in horses.docx

    Table 5_Road transportation is associated with decreased intestinal motility in horses.docx by Sharanne L. Raidal (3097719)

    Published 2025
    “…Horses with high heart rates, high sweat scores or abnormal demeanour on arrival demonstrated decreased intestinal motility. Salivary cortisol concentrations increased after transportation (mean difference, 95% CI, for T0 vs T1 was 1.66, 1.09−2.53 nmol/L) and were inversely associated with intestinal motility. …”
    Save to List
    Saved in:
  7. 7
    Table 6_Road transportation is associated with decreased intestinal motility in horses.docx

    Table 6_Road transportation is associated with decreased intestinal motility in horses.docx by Sharanne L. Raidal (3097719)

    Published 2025
    “…Horses with high heart rates, high sweat scores or abnormal demeanour on arrival demonstrated decreased intestinal motility. Salivary cortisol concentrations increased after transportation (mean difference, 95% CI, for T0 vs T1 was 1.66, 1.09−2.53 nmol/L) and were inversely associated with intestinal motility. …”
    Save to List
    Saved in:
  8. 8
    Table 7_Road transportation is associated with decreased intestinal motility in horses.xlsx

    Table 7_Road transportation is associated with decreased intestinal motility in horses.xlsx by Sharanne L. Raidal (3097719)

    Published 2025
    “…Horses with high heart rates, high sweat scores or abnormal demeanour on arrival demonstrated decreased intestinal motility. Salivary cortisol concentrations increased after transportation (mean difference, 95% CI, for T0 vs T1 was 1.66, 1.09−2.53 nmol/L) and were inversely associated with intestinal motility. …”
    Save to List
    Saved in:
  9. 9
    Table 1_Road transportation is associated with decreased intestinal motility in horses.docx

    Table 1_Road transportation is associated with decreased intestinal motility in horses.docx by Sharanne L. Raidal (3097719)

    Published 2025
    “…Horses with high heart rates, high sweat scores or abnormal demeanour on arrival demonstrated decreased intestinal motility. Salivary cortisol concentrations increased after transportation (mean difference, 95% CI, for T0 vs T1 was 1.66, 1.09−2.53 nmol/L) and were inversely associated with intestinal motility. …”
    Save to List
    Saved in:
  10. 10
    Table 4_Road transportation is associated with decreased intestinal motility in horses.docx

    Table 4_Road transportation is associated with decreased intestinal motility in horses.docx by Sharanne L. Raidal (3097719)

    Published 2025
    “…Horses with high heart rates, high sweat scores or abnormal demeanour on arrival demonstrated decreased intestinal motility. Salivary cortisol concentrations increased after transportation (mean difference, 95% CI, for T0 vs T1 was 1.66, 1.09−2.53 nmol/L) and were inversely associated with intestinal motility. …”
    Save to List
    Saved in:
  11. 11
    The introduction of mutualisms into assembled communities increases their connectance and complexity while decreasing their richness.

    The introduction of mutualisms into assembled communities increases their connectance and complexity while decreasing their richness. by Gui Araujo (22170819)

    Published 2025
    “…<p>Using the invasion model, we investigate the effect of switching on and off (black vs grey) invasions with mutualisms halfway through the simulation (i.e. after 500 assembly events). …”
    Save to List
    Saved in:
  12. 12
    HSP90 inhibition by RGRN-305 and 17-AAG decreased proinflammatory protein secretion.

    HSP90 inhibition by RGRN-305 and 17-AAG decreased proinflammatory protein secretion. by Hakim Ben Abdallah (14578241)

    Published 2024
    Save to List
    Saved in:
  13. 13
    Participants characteristics.

    Participants characteristics. by Sakiko Fukui (387048)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    A flow diagram of the study entry.

    A flow diagram of the study entry. by Sakiko Fukui (387048)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Supplementary Material for: Longitudinal Decrease in Left Ventricular Size with Age: Impact on Mortality and Cardiovascular Hospitalization

    Supplementary Material for: Longitudinal Decrease in Left Ventricular Size with Age: Impact on Mortality and Cardiovascular Hospitalization by figshare admin karger (2628495)

    Published 2025
    “…This study investigated clinical characteristics and outcomes associated with longitudinal decreases in LV size in this population. Methods: We analyzed echocardiographic data from 6,232 adults with normal baseline left ventricular end-diastolic diameter (LVEDD), with a mean interval of 4.8 years between baseline and follow-up echocardiograms. …”
    Save to List
    Saved in:
  16. 16
    Illustration of BSC control using ANN for WECS.

    Illustration of BSC control using ANN for WECS. by Abdelfattah Dani (22226715)

    Published 2025
    Save to List
    Saved in:
  17. 17
    Baseline patient characteristics across neutralizing monoclonal antibody trials.

    Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies.

    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: